Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Military Medicine|May 12, 2016
Intra-Arterial Perimortem Resuscitation Using a Micellar ColloidCuthbert Simpkins, Krishna Talluri, Mallory WilliamsPlos One|March 9, 2026
GIS-based land suitability evaluation and multi-criteria decision analysis for sustainable enset (Ensete ventricosum (Welw.) Cheesman) cultivation in Hadiya Zone, Central EthiopiaAlemu Ersino Ersado, Venkata Krishna TalluriCureus|March 29, 2021
Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With TocilizumabKrishna Talluri, Naveena Lall, Marcos A Moreno, et al.Human Psychopharmacology|August 21, 2009
No pharmacokinetic interaction between paliperidone extended-release tablets and trimethoprim in healthy subjectsAn Thyssen, Adriaan Cleton, Krishna Talluri, et al.Journal of Psychopharmacology (Oxford, England)|October 15, 2009
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophreniaJoris Berwaerts, Adriaan Cleton, Stefaan Rossenu, et al.Epilepsy & Behavior : E&B|October 2, 2010
Socioeconomic status and self-management in epilepsy: comparison of diverse clinical populations in Houston, TexasCharles E Begley, Ross Shegog, Biebele Iyagba, et al.Journal of Clinical Pharmacology|August 29, 2009
Single- and multiple-dose pharmacokinetics and dose proportionality of the psychotropic agent paliperidone extended releaseSandra Boom, Krishna Talluri, Luc Janssens, et al.International Clinical Psychopharmacology|August 11, 2007
A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophreniaRemy Luthringer, Luc Staner, Nadine Noel, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2008
Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humansMarc Vermeir, Ineke Naessens, Bart Remmerie, et al.Eclinicalmedicine|March 28, 2024
Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trialCuthbert Simpkins, Michael Moncure, Heather Klepacz, et al.Pageof 1